In this article, European Pharmaceutical Review’s Hannah Balfour explores some of big pharma’s latest developments in HIV treatment, with commentary from ViiV Healthcare’s Head of Research and Development, Kimberly Smith.
List view / Grid view
Antiretroviral therapy (ART)
The European Commission approval of the long-acting injectable HIV treatment could transform the lives of people living with the disease.
Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
Broadly neutralising antibody treatment may target viral reservoir in monkeys...